by Tony Dammicci | Nov 19, 2024 | Press Releases
The studies further strengthen HeartBeam’s body of clinical evidence for its portable, cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead ECG The first study is a pilot study demonstrating similar performance of HeartBeam’s...
by Tony Dammicci | Nov 15, 2024 | Press Releases
Addison, Texas, Nov. 15, 2024 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Thursday November 21, 2024 at 4:30 p.m....
by Tony Dammicci | Nov 13, 2024 | Press Releases
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol “IZTC” Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially...
by Tony Dammicci | Nov 12, 2024 | Press Releases
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol “IZTC” Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially...
Recent Comments